Persistent Systems Q4 FY26: Revenue $436m, BUY TP ₹6,200
Q4FY26 print: revenue at USD 436 million
Persistent Systems (PSYS) reported revenue of USD 436 million for Q4FY26, as per the brokerage note cited in the provided text. While the excerpt does not detail the full quarterly break-up by verticals or geographies, it frames the quarter as a softer exit compared with expectations in parts of the sell-side community. That softer exit is also reflected in later estimate revisions, which factor in continued investments.
The Q4 update is being discussed alongside multiple brokerage views, with Motilal Oswal reiterating its constructive stance. At the same time, some houses have flagged valuation as a near-term hurdle even when they acknowledge execution consistency.
FY26 scorecard: growth, cash conversion, and RoE
For FY26, the note states that revenue, adjusted EBIT, and adjusted PAT grew 23.5%, 36.6%, and 3.79% year-on-year, respectively, in INR terms. The same excerpt highlights a strong cash conversion, with free cash flow at 94.7% of net profit for FY26.
Return metrics also improved. FY26 RoE came in at 27.3%, compared with 24.8% in FY25, 25.6% in FY24, and 25.9% in FY23, as cited.
Deal momentum: TCV trends and book-to-bill
The text reports TTM TCV of USD 601 million, which was down 10.8% quarter-on-quarter and up 16.1% year-on-year, with a 1.4x book-to-bill. While TCV does not always translate one-to-one into near-term revenue, investors typically track it for demand signals and medium-term visibility, especially for mid-cap IT services firms.
In another excerpted note (earlier period), TTM TCV was cited at USD 520.8 million, up 1% QoQ and up 12% YoY, with a 1.3x book-to-bill. The two figures appear to be from different points in time, but together they show how sell-side notes are tracking order intake and conversion.
Outlook: estimate cut and margin path through FY28E
Motilal Oswal’s outlook in the excerpt says it cut estimates by around 4% to 5%, citing a soft Q4 exit and continued reinvestments in AI platforms and consulting capabilities. The same note says it now builds in a more gradual margin expansion to around 16.7% to 16.8% over FY27-28E.
That framing is important because it ties valuation to how quickly operating leverage flows through, particularly when the company is reinvesting for new capability build-outs.
Near-term growth expectations flagged by the note
The excerpt states expectations for 1QFY27 growth of 26.9% in revenue, 38.9% in adjusted EBIT, and 34.8% in adjusted PAT, year-on-year. Separately, another Motilal Oswal excerpt (earlier period) notes 1QFY26 revenue of USD 390 million, up 3.9% QoQ in USD terms and 3.3% in constant currency, and projects 2QFY26 YoY growth of 20.8% in revenue, 35.3% in EBIT, and 36.9% in PAT.
These multiple datapoints underline that broker models are balancing strong year-on-year growth math with quarter-on-quarter moderation and reinvestment costs.
Valuation framework and target prices: what brokerages are saying
One Motilal Oswal view in the text values PSYS at 34x FY28E EPS and reiterates BUY with a target price of ₹6,200. Elsewhere in the supplied excerpts, Motilal Oswal is also cited with different targets across time, including ₹6,450, ₹6,550 (from ₹6,400), and ₹6,800 in different notes.
Other brokerages referenced include:
- Nomura: retained Neutral and raised target to ₹5,200 from ₹5,000 (in one excerpt); in another, it lowered target to ₹5,000 from ₹5,600 at 36x FY27E EPS, citing macro risks.
- Emkay: Reduce, target ₹5,000.
- Nuvama: Buy, target ₹7,000 (from ₹6,600).
- JM Financial: Buy, target ₹6,140 (from ₹5,870).
- Choice Institutional Equities: Add, target ₹6,050.
- Antique: Hold, target ₹5,350.
Stock move and a snapshot of market positioning
In a time-stamped update in the text, Persistent Systems shares were reported up 6.29% at ₹5,658.9 at 9:22 AM. The excerpts also note a valuation comparison: Persistent Systems trading at a premium P/E of around 45x, versus peers TCS at 35x and Infosys at 28x, with the premium linked to its investments in AI and digital services.
That comparison sits at the heart of the divergence in ratings. Bulls focus on execution and AI-led opportunity, while cautious notes focus on how much of that optimism is already priced in.
Risks highlighted: revenue moderation and AI talent competition
The supplied text flags key risks for Persistent Systems, including five consecutive quarters of revenue moderation (excluding software licenses). It also points to intense competition for AI talent across the broader IT industry.
Both risk factors matter for near-term sentiment because they can influence growth durability and cost structure, even when demand for AI-related work remains strong.
Key numbers at a glance
Why the mix of views matters for investors
The excerpts collectively show a market debate that is common in mid-cap IT services: strong delivery and high growth visibility versus valuation comfort. On one side, Motilal Oswal continues to anchor its BUY thesis on execution and the strategic push into AI platforms and consulting. On the other, houses like Nomura and Emkay are more valuation-conscious, keeping targets around the ₹5,000 zone in the cited notes.
For investors, the practical takeaway from the supplied material is that the near-term narrative is being driven by (1) the pace of margin expansion amid reinvestment, (2) the consistency of deal conversion as captured by TCV and book-to-bill, and (3) whether growth can re-accelerate after the moderation referenced in the text.
Conclusion
Persistent Systems’ Q4FY26 revenue of USD 436 million, strong FY26 RoE of 27.3%, and 94.7% free-cash-flow-to-profit conversion provide a supportive fundamental backdrop in the excerpts. But the same text also captures why broker targets vary widely, with valuation and growth moderation risks still in focus. The next set of quarterly updates and management commentary on reinvestment pace and margin trajectory toward 16.7% to 16.8% over FY27-28E will remain key checkpoints cited by the street.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker